| Impairment of both nitric oxide‐mediated and EDHF‐type relaxation in small mesenteric arteries from rats with streptozotocin‐induced diabetes CH Leo, JL Hart, OL Woodman British journal of pharmacology 162 (2), 365-377, 2011 | 133 | 2011 |
| Vascular actions of relaxin: nitric oxide and beyond CH Leo, M Jelinic, HH Ng, SA Marshall, J Novak, M Tare, KP Conrad, ... British journal of pharmacology 174 (10), 1002-1014, 2017 | 109 | 2017 |
| Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment M Jelinic, CH Leo, EDP Uiterweer, SL Sandow, JH Gooi, ME Wlodek, ... The FASEB Journal 28 (1), 275, 2014 | 97 | 2014 |
| Acute intravenous injection of serelaxin (recombinant human relaxin‐2) causes rapid and sustained bradykinin‐mediated vasorelaxation CH Leo, M Jelinic, HC Parkington, M Tare, LJ Parry Journal of the American Heart Association 3 (1), e000493, 2014 | 65 | 2014 |
| Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes HH Ng, CH Leo, D Prakoso, C Qin, RH Ritchie, LJ Parry Scientific Reports 7 (1), 39604, 2017 | 59 | 2017 |
| 3′, 4′-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries CH Leo, JL Hart, OL Woodman PLoS One 6 (6), e20813, 2011 | 57 | 2011 |
| Flavonols in the prevention of diabetes-induced vascular dysfunction CH Leo, OL Woodman Journal of cardiovascular pharmacology 65 (6), 532-544, 2015 | 56 | 2015 |
| Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice HH Ng, M Jelinic, LJ Parry, CH Leo American Journal of Physiology-Heart and Circulatory Physiology 309 (2 …, 2015 | 50 | 2015 |
| Short-term type 1 diabetes alters the mechanism of endothelium-dependent relaxation in the rat carotid artery CH Leo, A Joshi, OL Woodman American Journal of Physiology-Heart and Circulatory Physiology 299 (2 …, 2010 | 50 | 2010 |
| Three-dimensional printing of food foams stabilized by hydrocolloids for hydration in dysphagia AY Lee, A Pant, K Pojchanun, CP Lee, J An, M Hashimoto, UX Tan, ... International Journal of Bioprinting 7 (4), 2021 | 49 | 2021 |
| Serelaxin: a novel therapeutic for vascular diseases CH Leo, M Jelinic, HH Ng, M Tare, LJ Parry Trends in pharmacological sciences 37 (6), 498-507, 2016 | 49 | 2016 |
| Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta HH Ng, CH Leo, LJ Parry Pharmacological research 107, 220-228, 2016 | 47 | 2016 |
| Systematic Engineering approach for optimization of multi-component alternative protein-fortified 3D printing food Ink Y Zhang, AY Lee, K Pojchanun, CP Lee, A Zhou, J An, M Hashimoto, ... Food Hydrocolloids 131, 107803, 2022 | 46 | 2022 |
| Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta CH Leo, A Joshi, JL Hart, OL Woodman Pharmacological research 66 (5), 383-391, 2012 | 44 | 2012 |
| Relaxin as a therapeutic target for the cardiovascular complications of diabetes HH Ng, CH Leo, LJ Parry, RH Ritchie Frontiers in pharmacology 9, 501, 2018 | 43 | 2018 |
| Time‐dependent activation of prostacyclin and nitric oxide pathways during continuous iv infusion of serelaxin (recombinant human H2 relaxin) CH Leo, M Jelinic, HH Ng, M Tare, LJ Parry British journal of pharmacology 173 (6), 1005-1017, 2016 | 43 | 2016 |
| Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice SA Marshall, CH Leo, SN Senadheera, JE Girling, M Tare, LJ Parry American Journal of Physiology-Regulatory, Integrative and Comparative …, 2016 | 42 | 2016 |
| A vasoactive role for endogenous relaxin in mesenteric arteries of male mice CH Leo, M Jelinic, JH Gooi, M Tare, LJ Parry PLoS One 9 (9), e107382, 2014 | 42 | 2014 |
| Gut-derived metabolite, trimethylamine-N-oxide (TMAO) in cardio-metabolic diseases: detection, mechanism, and potential therapeutics M Shanmugham, S Bellanger, CH Leo Pharmaceuticals 16 (4), 504, 2023 | 37 | 2023 |
| Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction SA Marshall, CH Leo, JE Girling, M Tare, S Beard, NJ Hannan, LJ Parry Biology of reproduction 96 (4), 895-906, 2017 | 37 | 2017 |
